Infirst Limited, a privately-owned UK healthcare company focused on improving existing medicines, today confirms that its flagship product Flarin is to be tested as a treatment for certain symptoms of hospitalised COVID-19 patients.
Infirst Limited, a privately-owned UK healthcare company focused on improving existing medicines, today confirms that its flagship product Flarin is to be tested as a treatment for certain symptoms of hospitalised COVID-19 patients.